iLearningEngines logo.jpg
iLearningEngines and GenLab Venture Studio Announce Strategic Alliance to fast-track Enterprise AI Applications Using Generative AI within Global Enterprises
September 18, 2024 17:00 ET | iLearningEngines Holdings, Inc.
BETHESDA, Md., Sept. 18, 2024 (GLOBE NEWSWIRE) -- iLearningEngines, Inc. (Nasdaq: AILE) (“iLearningEngines,” “ILE,” or “the Company”), a leader in AI-powered learning and work automation for...
fanhua_logo.jpg
Fanhua Reports First Half 2024 Unaudited Financial Results
September 18, 2024 17:00 ET | Fanhua Inc.
GUANGZHOU, China, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Fanhua Inc. (Nasdaq: FANH) (the “Company” or “Fanhua”), a leading independent financial services provider in China, today announced its unaudited...
Aligos.png
Aligos Therapeutics to Announce Topline Results from the Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024
September 18, 2024 17:00 ET | Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient...
Cytek Logo - Color.jpg
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET | Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
ultragenyx-CMYK.png
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2024 17:00 ET | Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Stellantis N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action – STLA
September 18, 2024 16:53 ET | The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LEADING LAW FIRM, Encourages Sprinklr, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CXM
September 18, 2024 16:49 ET | The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June...
PAINWeek 2024 Unites
PAINWeek 2024 Unites Nearly 2,000 Clinicians to Revolutionize Pain Management
September 18, 2024 16:45 ET | PAINWeek
Las Vegas, Nevada, Sept. 18, 2024 (GLOBE NEWSWIRE) -- PAINWeek 2024, the largest pain management conference in the United States, concluded its four-day run from September 3-6 at the iconic...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM
September 18, 2024 16:40 ET | The Rosen Law Firm PA
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022...
robbins-llp-logo-white-background1583450-1.png
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against New Fortress Energy Inc.
September 18, 2024 16:35 ET | Robbins LLP
Robbins LLP is Investigating Allegations that New Fortress Energy Inc. (NFE) Misled Investors Regarding its Growth Projections